This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated YTHDF3 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-YTHDF3 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~63.9 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Acetylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A14443 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of Mouse liver, (catalog A14443) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A14443) |
| Primary antibody | A14443 · 1:1000 (catalog A14443) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A14443) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A14443) |
YTHDF3 is predicted at 63.9 kDa; Ser2 acetylation and Ser23 phosphorylation are annotated, but their effects on migration are not demonstrated.
| Band near 63.9 kDa | Consistent with the predicted full-length YTHDF3 mass; confirm identity with controls. |
| Closely spaced bands near 63.9 kDa | Ser23 phosphorylation is a possible contributor, but distinct migration is unproven. |
| Band near 63.9 kDa without a visible shift | Ser2 acetylation need not produce a resolvable shift. |
| Band in a cytosolic fraction | Consistent with YTHDF3 localization in the cytosol. |
| UniProt predicted mass | Places the full-length protein near 63.9 kDa. |
| 585-residue sequence | Defines the full-length protein underlying the predicted mass. |
| Ser2 N-acetylserine | Adds a small modification without an established visible shift. |
| Ser23 phosphoserine | May affect mobility, but no distinct band position is established. |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Low YTHDF3 signal or poor recovery from its cytosolic compartment. | Check loading and detection with a cytosolic positive control. |
| Band higher than expected | Band identity or a mobility effect is unverified; Ser23 phosphorylation is annotated. | Compare phosphatase-treated samples and confirm identity with an independent antibody or knockdown. |
| Band lower than expected | Possible degradation; no cleavage feature is annotated. | Prepare fresh lysate with protease inhibitors and confirm identity by knockdown. |
| Multiple bands | Phosphorylation is possible, but separate YTHDF3 bands are not established. | Compare phosphatase treatment and knockdown to identify YTHDF3-dependent bands. |
| Weak or no signal | Insufficient cytosolic protein or detection sensitivity. | Verify protein loading and use a YTHDF3-positive cytosolic sample. |
| Fragments below expected size | Possible sample degradation rather than annotated processing. | Prepare fresh lysate with protease inhibitors and check whether fragments track with YTHDF3 knockdown. |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for YTHDF3, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
A14443 is listed as reactive with human, mouse, and rat YTHDF3. The supplied Western blot caption documents mouse liver extract tested at 1:1000 antibody dilution; it provides no human or rat blot examples.
Which to pick: A14443 is the only listed option and has a Western blot image from mouse liver extract. For other sample types, the supplied evidence does not show a blot.